FDA Approved: FLUVOXAMINE MALEATE — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved Bionpharma's original application for fluvoxamine maleate, an SSRI indicated for obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Fluvoxamine Maleate (Fluvoxamine maleate)

Snippet

ORIG AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)